To provide men, initially within Europe and parts of North America, with first line treatment for Erectile Dysfunction (ED) and Benign Prostatic Hyperplasia (BPH) through the supply of safe, effective and affordable generic drugs.
MANAGEMENT TEAM MEMBERS
Chairman and CEO, BioPharmcor Group
Michael S. Wexler
Contributes over 40 years of hands on business experience in the Polish and international markets. Has extensive experience and know-how in the Business Consulting sector with senior level management positions in the Health Industry since 1992. More
Board Member and CMO of Biopharmcor B.V. and wholly owned Polish subsidiary, Biopharmcor Sp. z o.o.
Dr Anthony J. Bella
A highly regarded urologist and surgeon, Dr. Bella specializes in the treatment of a wide spectrum of urological disorders in Men including Erectile Dysfunction (ED) and Benign Prostatic Hyperplasia (BPH). More
Board Member of Biopharmcor Sp. z o.o. and wholly owned Polish subsidiary Biopharmcor B.V.
Thomas M. Edmond
Mr. Edmond brings his long experience and training in senior positions in the Insurance industry at an International level to his Board positions at the BioPharmcor Group. More
Chief Financial Officer (CFO) of the Biopharmcor Group
Robert J. Wassink
A fully accredited accountant (CPA) in The Netherlands, Mr. Wassink has extensive experience and training in corporate financial management. having held senior management positions with some of the world’s leading accounting firms as well as a major bank. More
Director, Pharmaceutical Development
Dr Stuart Madden
Dr. Madden is responsible for co-ordinating all of BioPharmcor’s development programs with its global partner, Kabs Laboratories. He brings to the Company over 30 years of experience and know how in the pharmaceutical industry in regards to the formulation, development and commercialisation of medical products. More
Director, Investor Relations and Corporate Communications
With over 15 years of training and work experience in the financial and insurance sectors. Mr. Mrotek plays a key role in the preparation and execution of Company sponsored funding programs. He is responsible for all liaison activities with investors and partners in Poland and throughout the EU. More